ALPHAMAB-B 09966Hong Kong Stock Exchange

7.3552.45%( -0.185 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
ALPHAMAB-B (09966) Financials - Earnings, Key Metrics & Statements - cibo

FY2025 Annual Report

Reporting period: 2025.01.01-2025.12.31

Summary: ALPHAMAB-B (09966) reported Revenue of 566.24M(-11.54%); Operating profit of -106.49M(-160.41%); Net profit attributable to owners of -113.94M(-168.50%).

ReportedYoY
Prior YearYoY
RevenueDown YoY
566.24M11.54%
640.08M192.58%
Operating profitDown YoY
-106.49M160.41%
176.27M188.84%
Net profit attributable to ownersDown YoY
-113.94M168.50%
166.34M178.99%

Revenue

ReportedUnit: CNY

Operating profit

ReportedUnit: CNY

Net profit attributable to owners

ReportedUnit: CNY

Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.

About this page

This page shows ALPHAMAB-B (09966) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.